{"entity":{"type":"insider","cik":"0001511034","url":"/insider/0001511034","json_url":"/insider/0001511034.json","name":"Mahatme Sandesh","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":10,"n_filings":7,"first":"2013-08-20","last":"2019-12-17","span_basis":"filed_date"},"name_variants":[{"name":"Mahatme Sandesh","source":"filing","n_filings":7,"first_seen":"2013-08-20","last_seen":"2019-12-17"}],"transactions":[{"id":8103672,"accession":"0001209191-19-061048","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-061048","line_url":"/filing/0001209191-19-061048#line-7","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":125000.0,"shares_display":"125,000","price_per_share":125.5,"price_display":"125.50","price_state":"stated","total_value":15687500.0,"total_display":"15,687,500.00","shares_owned_after":30179.0,"shares_owned_after_display":"30,179","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-12-13","filed_date":"2019-12-17","scope":"insider"},{"id":7874994,"accession":"0001209191-19-008776","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-19-008776","line_url":"/filing/0001209191-19-008776#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":65000.0,"shares_display":"65,000","price_per_share":145.0,"price_display":"145.00","price_state":"stated","total_value":9425000.0,"total_display":"9,425,000.00","shares_owned_after":8649.0,"shares_owned_after_display":"8,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-02-07","filed_date":"2019-02-08","scope":"insider"},{"id":8691504,"accession":"0001209191-19-006627","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-19-006627","line_url":"/filing/0001209191-19-006627#line-7","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":21198.0,"shares_display":"21,198","price_per_share":130.72,"price_display":"130.72","price_state":"stated","total_value":2771002.56,"total_display":"2,771,002.56","shares_owned_after":8649.0,"shares_owned_after_display":"8,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-31","filed_date":"2019-02-01","scope":"insider"},{"id":8691498,"accession":"0001209191-19-006627","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-19-006627","line_url":"/filing/0001209191-19-006627#line-5","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":43802.0,"shares_display":"43,802","price_per_share":130.0,"price_display":"130.00","price_state":"stated","total_value":5694260.0,"total_display":"5,694,260.00","shares_owned_after":8649.0,"shares_owned_after_display":"8,649","ownership_form":"D","is_10b5_1":null,"transaction_date":"2019-01-30","filed_date":"2019-02-01","scope":"insider"},{"id":6498633,"accession":"0001209191-18-056332","txn_seq":7,"anchor":"line-7","filing_url":"/filing/0001209191-18-056332","line_url":"/filing/0001209191-18-056332#line-7","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":107524.0,"shares_display":"107,524","price_per_share":127.74,"price_display":"127.74","price_state":"stated","total_value":13735115.76,"total_display":"13,735,115.76","shares_owned_after":20661.0,"shares_owned_after_display":"20,661","ownership_form":"D","is_10b5_1":null,"transaction_date":"2018-10-24","filed_date":"2018-10-26","scope":"insider"},{"id":4944200,"accession":"0001209191-17-046039","txn_seq":6,"anchor":"line-6","filing_url":"/filing/0001209191-17-046039","line_url":"/filing/0001209191-17-046039#line-6","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":32998.0,"shares_display":"32,998","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":1352918.0,"total_display":"1,352,918.00","shares_owned_after":32361.0,"shares_owned_after_display":"32,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":4944195,"accession":"0001209191-17-046039","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0001209191-17-046039","line_url":"/filing/0001209191-17-046039#line-5","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9375.0,"shares_display":"9,375","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":384375.0,"total_display":"384,375.00","shares_owned_after":32361.0,"shares_owned_after_display":"32,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":4944191,"accession":"0001209191-17-046039","txn_seq":4,"anchor":"line-4","filing_url":"/filing/0001209191-17-046039","line_url":"/filing/0001209191-17-046039#line-4","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (EVP, CFO & CBO)","officer_title":"EVP, CFO & CBO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7627.0,"shares_display":"7,627","price_per_share":41.0,"price_display":"41.00","price_state":"stated","total_value":312707.0,"total_display":"312,707.00","shares_owned_after":32361.0,"shares_owned_after_display":"32,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-07-20","filed_date":"2017-07-21","scope":"insider"},{"id":3295189,"accession":"0001209191-16-146354","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-16-146354","line_url":"/filing/0001209191-16-146354#line-2","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (Senior Vice President, CFO)","officer_title":"Senior Vice President, CFO","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":30000.0,"shares_display":"30,000","price_per_share":50.0834,"price_display":"50.08","price_state":"stated","total_value":1502502.0,"total_display":"1,502,502.00","shares_owned_after":31532.0,"shares_owned_after_display":"31,532","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-10-17","filed_date":"2016-10-19","scope":"insider"},{"id":5067690,"accession":"0001181431-13-045673","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001181431-13-045673","line_url":"/filing/0001181431-13-045673#line-1","is_derivative":false,"issuer_cik":"0000873303","issuer_name":"Sarepta Therapeutics, Inc.","issuer_ticker":"SRPT","issuer_name_source":null,"issuer_url":"/issuer/0000873303","owner_cik":"0001511034","owner_name":"Mahatme Sandesh","owner_url":"/insider/0001511034","role":"Officer (Senior Vice President, CFO)","officer_title":"Senior Vice President, CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":31.1,"price_display":"31.10","price_state":"stated","total_value":155500.0,"total_display":"155,500.00","shares_owned_after":5000.0,"shares_owned_after_display":"5,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-20","filed_date":"2013-08-20","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":10,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":1,"open_market":true},{"code":"S","label":"Open-market sale","n":9,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":10},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0000873303","name":"Sarepta Therapeutics, Inc.","url":"/issuer/0000873303","role":"Officer (EVP, CFO & CBO)","n_filings":7,"first_seen":"2013-08-20","last_seen":"2019-12-17"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001511034","retrieved_at":"2026-08-21T01:12:24+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-19","last_ingest":"2026-08-20T05:22:56.381658+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}